PRVL - Prevail Therapeutics Inc
Previous close
23
0 0%
Share volume: 0
Last Updated: Thu 21 Jan 2021 06:00:00 AM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$23.00
0.00
0.00%
Summary score
28%
Profitability
25%
Dept financing
18%
Liquidity
50%
Performance
27%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.49%
Return on assets
-10.45%
Return on sales
0%
Return on invested capital
-828.27%
Total debt ratio
11.24%
Debt ratio change over timeo
-1.02%
Current Ratio
16.79%
Quick Ratio
0%
Cash Position Ratio
16.15%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.91%
Return on assets
-11.63%
Return on sales
0%
Return on invested capital
-1008.13%
Total debt ratio
12.21%
Debt ratio change over timeo
-1.01%
Current Ratio
13.9%
Quick Ratio
0%
Cash Position Ratio
13.27%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-17.18%
Return on assets
-14.7%
Return on sales
0%
Return on invested capital
-140.9%
Total debt ratio
14.62%
Debt ratio change over time
-1.03%
Current Ratio
9.5%
Quick Ratio
0%
Cash Position Ratio
8.63%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.02%
Return on assets
-98.18%
Return on sales
0%
Return on invested capital
50.21%
Total debt ratio
-101.82%
Debt ratio change over time
-1.02%
Current Ratio
-4.81%
Quick Ratio
0%
Cash Position Ratio
-4.69%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRVL | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -11.49% | -4.61% | -11.83% | 0% |
| Return on assets | -10.45% | -4.6% | -10.3% | 0% |
| Return on sales | 0% | -37.29% | 0% | 0% |
| Return on invested capital | -828.27% | 265.33% | -27.14% | 0% |
| Profitability | 25% | 25% | 0% | 50% |
| Total debt ratio | 11.24% | 18.22% | 14.3% | 0% |
| Debt ratio change over time | -1.02% | -1.66% | -1.56% | 0% |
| Dept financing | 15% | 25% | 20% | 25% |
| Current Ratio | 13.9% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 13.27% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 32% | 13% | 0% |
| Short-term ratios | PRVL | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -12.91% | -3.62% | -13.55% | 0% |
| Return on assets | -11.63% | -3.93% | -11.56% | 0% |
| Return on sales | 0% | -34.27% | 0% | 0% |
| Return on invested capital | -1008.13% | -9.88% | -24.84% | 0% |
| Profitability | 25% | 0% | 0% | 75% |
| Total debt ratio | 12.21% | 15.47% | 15.89% | 0% |
| Debt ratio change over time | -1.01% | -0.59% | -1.72% | 0% |
| Dept financing | 19% | 24% | 25% | 25% |
| Current Ratio | 13.9% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 13.27% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 35% | 14% | 0% |